Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 10:10 AM ET


Company Overview of Synthetic Genomics, Inc.

Company Overview

Synthetic Genomics, Inc., a synthetic biology company, develops and commercializes genomic-driven solutions and products for various industries worldwide. The company focuses on various commercialization programs, including developing synthetic DNA products, tools, and instruments for organizations with demands for large and/or complex DNA constructs; algae based food and nutritional products, and biofuels; and synthetically-derived vaccines and anti-microbials. It also develops clean water technologies using microbial fuel cells; and sustainable agricultural products. Synthetic Genomics, Inc. was formerly known as Synthetic Genomic Solutions, Inc. The company was founded in 2005 and is base...

11149 North Torrey Pines Road

La Jolla, CA 92037

United States

Founded in 2005





Key Executives for Synthetic Genomics, Inc.

Chief Executive Officer and Director
Age: 51
Co-Founder, Executive Chairman and Co-Chief Scientific Officer
Co-Founder, Co-Chief Scientific Officer and Director
Co-Founder, Executive Vice President, General Counsel and Director
Co-Founder, Chief Business Officer and Director
Age: 55
Compensation as of Fiscal Year 2015.

Synthetic Genomics, Inc. Key Developments

Synthetic Genomics Expands Multi-Year Research and Development Agreement with Lung Biotechnology PBC

Synthetic Genomics has expanded its multi-year research and development agreement with Lung Biotechnology PBC. The contract has been signed to develop transplantation-ready pig organs using synthetic genomic advances. Both firms initially focused efforts on lung diseases and will now also include kidney diseases. Under the contract, SGI will receive royalties and milestones from the development and commercialization of the organs.

Synthetic Genomics, Inc. Presents at World Congress on Industrial Biotechnology, Jul-22-2015 08:30 AM

Synthetic Genomics, Inc. Presents at World Congress on Industrial Biotechnology, Jul-22-2015 08:30 AM. Venue: Palais des congrès de Montréal, Montréal, Quebec, Canada. Speakers: Thomas Ishoey, Vice President of Product & Technology Development.

Synthetic Genomics, Inc. and Gen9 Sign Licensing Agreement for Synthetic Biology Technology Patents

Synthetic Genomics, Inc. and Gen9 Inc. announced a strategic licensing agreement to leverage their respective strengths in synthetic biology technology development and commercialization. The agreement provides Gen9 Inc. with a non-exclusive worldwide license to SGI's Febit intellectual property estate. The financial details of the agreement were not disclosed.

Similar Private Companies By Industry

Company Name Region
Collateral Therapeutics Inc. United States
Convoy Therapeutics, Inc. United States
Cytogam, Inc. United States
Cencor Biotech Inc. United States
Cantex Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Private Placement
September 22, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Synthetic Genomics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at